Immix Biopharma, Inc. (NASDAQ:IMMX – Get Free Report) was down 9% during mid-day trading on Monday . The stock traded as low as $1.61 and last traded at $1.62. Approximately 84,599 shares traded hands ...
See also Lazarus Group at it again - New victim suspected in $3.1M Tron hack Next is Immutable X (IMX) with 24.52 million tokens valued ... Pixel Protocol (PIXEL) will also release 91.18 million ...
The move to allow in-kind redemptions and creations streamlines ETF trading efficiency, bypassing the need for cash.
Prices for Floki, Turbo, and Giga were little changed despite Coinbase announcing the suspension of trading on its platform ...
Still, there's a risk-off feeling in the air as the divergence between bitcoin and the broader crypto market grows. Bitcoin ...
The crypto market continues to lose ground, driven by disappointment over the absence of a plan for the U.S. government to buy bitcoin under the newly announced strategic reserve plan and amid ...
Our 22News Skycam could see that the right lane was closed to traffic, but it has since reopened, According to Waze, the traffic was backed up to Longmeadow. The Massachusetts State Police says ...
Adjusted EPS grew to $0.27 from $0.26 in Q3. Revenues rose to $93 million in Q4, compared to $91.5 million in Q3, driven by stronger box office results in the holiday period. Management tone was ...
This article picked by a teacher with suggested questions is part of the Financial Times free schools access programme. Details/registration here. Read below a selection of FT articles picked by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback